Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Pki source : Www.biospace.com save search
PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform
Published: 2023-12-04 (Crawled : 13:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
global diagnostics platform
Revvity Announces Financial Results for the First Quarter of 2023
Published: 2023-05-11 (Crawled : 12:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -7.32%
H: 2.39%
C: 1.02%
financial results
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
Published: 2023-04-12 (Crawled : 13:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 1.28%
H: 0.61%
C: -0.66%
Dirk Bontridder Appointed as CEO of New PerkinElmer Business Acquired by New Mountain Capital
Published: 2023-03-20 (Crawled : 12:20) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -2.64%
H: 2.21%
C: 1.27%
ceo business acquired
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Published: 2023-03-09 (Crawled : 14:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 2.49%
C: -0.52%
sciences life
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
Published: 2023-02-24 (Crawled : 13:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -3.06%
H: 0.0%
C: 0.0%
research
PerkinElmer to Present at Upcoming Investor Conferences - February 22, 2023
Published: 2023-02-22 (Crawled : 15:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.55%
H: 1.23%
C: 0.98%
Adolore Biotherapeutics Strengthens Management Team and Board of Directors with the Appointments of Roelof Rongen, MSE, MBA and Mark C. Rogers, MD, MBA
Published: 2023-01-17 (Crawled : 21:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
management
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
Published: 2022-11-21 (Crawled : 13:20) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -2.56%
H: 1.48%
C: 1.04%
research therapy
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
Published: 2022-11-14 (Crawled : 14:20) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 4.43%
H: 0.0%
C: 0.0%
fda authorization
PerkinElmer to Present at 2022 Stifel Healthcare Conference
Published: 2022-11-10 (Crawled : 13:20) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 3.88%
H: 5.14%
C: 4.91%
conference
PerkinElmer Board Declares Quarterly Dividend payable on February 10, 2023
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.56%
H: 0.84%
C: -0.59%
Genomma Lab Internacional Announces Third Dividend Payment - October 27, 2022 Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange...
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.56%
H: 0.84%
C: -0.59%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -3.82%
H: 6.9%
C: 6.49%
MIRM | News | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.48%
H: 2.41%
C: -7.81%
ARGX | $360.11 0.47% 0.47% 330K
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -3.71%
payment
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
Published: 2022-10-17 (Crawled : 12:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 1.49%
H: 3.14%
C: 2.14%
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
Published: 2022-10-13 (Crawled : 13:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -4.0%
H: 0.0%
C: 0.0%
disease capacity
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
Published: 2022-09-26 (Crawled : 12:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -1.01%
H: 2.14%
C: -0.95%
research therapy
PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
Published: 2022-09-22 (Crawled : 13:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -2.57%
H: 0.0%
C: 0.0%
fda t-cell approval
Movers & Shakers: Galera, Verily, Avid and More Tap New Execs
Published: 2022-09-02 (Crawled : 13:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: -1.7%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M
|
Health Technology
|
| O: -2.22%
H: 0.65%
C: -7.47%
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: 1.55%
H: 1.52%
C: -2.99%
PTCT | News S | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: 0.91%
H: 2.74%
C: -0.69%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: 0.73%
H: 1.81%
C: -0.36%
PerkinElmer to Present at Upcoming Investor Conferences
Published: 2022-08-24 (Crawled : 13:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.05%
H: 1.18%
C: 0.45%
PerkinElmer Announces Finance Leadership Transition
Published: 2022-08-17 (Crawled : 13:20) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: -0.95%
H: 0.5%
C: -2.49%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.